Efficacy of Green Tea Buccal Tablets in Oral Lichen Planus
Efficacy of 200mg and 300mg Concentrates of Green Tea Polyphenols Using Buccal Tablets Versus Topical Application of Corticosteroids in Treatment of Patients With Symptomic Oral Lichen Planus Randomized Clinical Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
Is topical application of green tea polyphenols buccal tablet more effective in treatment of patients with symptomatic oral lichen planus in comparison with topical application of corticosteroids and what is the most effective concentration of polyphenols
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for early_phase_1
Started Jan 2018
Shorter than P25 for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 3, 2018
CompletedFirst Submitted
Initial submission to the registry
January 22, 2018
CompletedFirst Posted
Study publicly available on registry
January 30, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2019
CompletedFebruary 13, 2018
January 1, 2018
1.1 years
January 22, 2018
February 11, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
size of the lesion
the shape and the measurement of its size
12 weeks
Secondary Outcomes (1)
visual analogue score
12 weeks
Study Arms (2)
green tea buccal tablet
ACTIVE COMPARATORbuccal tablet 3 times aday
corticosteroids topical
SHAM COMPARATORtopical steroids 3 times aday
Interventions
buccal tablet for 8 hrs 3 times aday
kenacort in orabase 4 times aday
Eligibility Criteria
You may qualify if:
- Symptomatic lesions.
- OLP lesions with the diagnosis confirmed both clinically and histopathologically.
- Clinical score higher than 3.
- Disease duration of more than 2 months.
- Absence of dysplasia in histological section
You may not qualify if:
- Presence of any visible oral lesion other than OLP.
- Pregnant or breast-feeding women,
- Immuno-deficiency diseases.
- Current malignancy or malignancy in history.
- Concomitant treatment potentially effective on OLP within the previous 2 months such as antimalarial agents, retinoids, corticosteroids or immunosuppressive drugs.
- Severe or recurrent infections.
- Lichenoid reaction.
- Patients presents with skin lesions which may require systemic corticosteroid therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Cairo University
Cairo, 00202, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
cairo university
cu
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- princible investigator EMagdy
Study Record Dates
First Submitted
January 22, 2018
First Posted
January 30, 2018
Study Start
January 3, 2018
Primary Completion
January 30, 2019
Study Completion
January 30, 2019
Last Updated
February 13, 2018
Record last verified: 2018-01